Scilex Holding Company (SCLX)

USD 5.44

(6.67%)

Operating Expenses Summary of Scilex Holding Company

  • Scilex Holding Company's latest annual operating expenses in 2023 was 136.49 Million USD , up 69.96% from previous year.
  • Scilex Holding Company's latest quarterly operating expenses in 2024 Q2 was 26.59 Million USD , down -14.76% from previous quarter.
  • Scilex Holding Company reported a annual operating expenses of 77.87 Million USD in annual operating expenses 2022, up 22.59% from previous year.
  • Scilex Holding Company reported a annual operating expenses of 63.52 Million USD in annual operating expenses 2021, up 12.09% from previous year.
  • Scilex Holding Company reported a quarterly operating expenses of 26.59 Million USD for 2024 Q2, down -14.76% from previous quarter.
  • Scilex Holding Company reported a quarterly operating expenses of 32.46 Million USD for 2023 Q1, up 19.59% from previous quarter.

Annual Operating Expenses Chart of Scilex Holding Company (2023 - 2019)

Historical Annual Operating Expenses of Scilex Holding Company (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 136.49 Million USD 69.96%
2022 77.87 Million USD 22.59%
2021 63.52 Million USD 12.09%
2020 56.66 Million USD -63.18%
2019 153.92 Million USD 0.0%

Peer Operating Expenses Comparison of Scilex Holding Company

Name Operating Expenses Operating Expenses Difference
Amgen Inc. 11.87 Billion USD 98.851%
AstraZeneca PLC 29.57 Billion USD 99.539%
Biogen Inc. 5.2 Billion USD 97.378%
Gilead Sciences, Inc. 13.01 Billion USD 98.951%
MIRA Pharmaceuticals, Inc. 8.52 Million USD -1500.894%
Scilex Holding Company 136.49 Million USD 0.0%